DataLend: Securities lending top 10 earning equities – November 5, 2014

DataLend presents its top 10 earnings equities for November 5, 2014. This list is built on DataLend’s universe of more than 42,000 securities on loan.

Methodology: We scan our universe of more than 42,000 securities on loan to find those securities with the most expensive financing positions in the U.S., U.K., Europe and Asia. Financing costs are determined by taking the total on-loan value of a security and multiplying it by the volume-weighted average fees to borrow that security, then converting the product of those numbers to a dollar value. We then sort the most expensive securities to finance in the securities lending market in descending order.

US

Utilization

1     GOPRO CL A 98.24%
2     AMTRUST FINANCIAL SERVICES 95.38%
3     3D SYSTEMS 94.18%
4     MYRIAD GENETICS 96.91%
5     DIAMOND OFFSHORE DRILLING 92.01%
6     BURGER KING WORLDWIDE 95.14%
7     LINDSAY 94.89%
8     SEARS HOLDINGS 86.19%
9     MOBILEYE 96.00%
10   ULTRA PETROLEUM 91.95%

UK

Utilization

1     SAINSBURYJ 82.84%
2     QUINDELL 96.02%
3     MONITISE 96.64%
4     ASHMORE GROUP 77.15%
5     LONMIN 83.83%
6     JSC VTB BANK GDR 48.13%
7     GULF KEYSTONE PETROLEUM 97.08%
8     SAGA 59.24%
9     JUST EAT 63.27%
10   STANDARD CHARTERED 3.77%

Europe

Utilization

1     GEMALTO (NL) 90.58%
2     SAINSBURYJ (GB) 82.84%
3     ROCKET INTERNET 63.16%
4     GEMALTO (FR) 93.57%
5     TRANSOCEAN (CH) 87.96%
6     QUINDELL 96.02%
7     NUMERICABLE GROUP 69.96%
8     SUEDZUCKER MANNHEIM OCHSENFURT (DE) 91.96%
9     COMPAGNIE GENERALE GEOPHYSIQUE (FR) 85.00%
10   TGS NOPEC GEOPHYSICAL (NO) 79.99%

Far East/Australia Pacific

Utilization

1     HANERGY TFP (HK) 89.67%
2     EVERGRANDE (HK) 87.63%
3     CELLTRION (KR) 73.05%
4     MIXI (JP) 93.94%
5     ANHUI CONCH H (HK) 65.39%
6     PRADA (HK) 91.31%
7     GUNGHO ONLINE (JP) 90.26%
8     GREE (JP) 94.14%
9     SANRIO (JP) 88.73%
10   HUISHAN DAIRY 72.96%

Click here for more information about DataLend’s key features.


THE INFORMATION CONTAINED HEREIN IS PROPRIETARY TO EQUILEND; MAY NOT BE COPIED OR DISTRIBUTED WITHOUT THE EXPRESS CONSENT OF EQUILEND; SHALL NOT CONSTITUTE INVESTMENT ADVICE BY EQUILEND, OR ANY REPRESENTATIVE THEREOF; IS NOT WARRANTED TO BE ACCURATE, COMPLETE OR TIMELY; IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY; IS NOT INTENDED FOR TRADING PURPOSES; AND SHOULD NOT BE CONSTRUED AS EQUILEND MAKING FORECASTS, PROJECTING RETURNS OR RECOMMENDING ANY PARTICULAR COURSE OF ACTION. NEITHER EQUILEND NOR ANY REPRESENTATIVE THEREOF SHALL BE AN ADVISOR OR A FIDUCIARY OF A VISITOR TO THIS WEBSITE. EQUILEND IS NOT RESPONSIBLE OR LIABLE IN ANY WAY TO THE READER OR VISITOR, OR TO ANY PERSON, FIRM OR CORPORATION FOR ANY DAMAGES OR LOSSES ARISING FROM ANY USE OF THE INFORMATION CONTAINED HEREIN. IN CONSIDERING THE INFORMATION CONTAINED HEREIN, A VISITOR TO THIS WEBSITE DOES SO SOLELY IN RELIANCE ON THE VISITOR’S OWN JUDGMENT. PAST PERFORMANCE IS NO GUARANTEE OF FUTURE PERFORMANCE.

Related Posts

Previous Post
FSB consults on proposal for a common international standard on Total Loss-Absorbing Capacity (TLAC) for global systemic banks
Next Post
ESMA consults on revised EMIR standards on the reporting to trade repositories

Fill out this field
Fill out this field
Please enter a valid email address.

X

Reset password

Create an account